Month: July 2022

AlzeCure Gets Abstract on New Clinical Study Data with NeuroRestore Accepted at the Alzheimer’s Conference AAIC

Staff July 5, 2022

STOCKHOLM, SWEDEN / ACCESSWIRE / July 5, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical...

Pharnext Appoints Antoine Gravelle as General Counsel

Staff July 5, 2022

PARIS, FRANCE / ACCESSWIRE / July 5, 2022 / Pharnext SA (FR0011191287-ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company...

Evotec Completes Acquisition of Rigenerand

Staff July 5, 2022

AS "EVOTEC CELL ACCELERATOR", THE HIGH-QUALITY CGMP CELL THERAPY MANUFACTURING SITE ADDS CAPACITY AND CAPABILITYEVOTEC'S EVO CELLS PLATFORM INTEGRATES INNOVATIVE...

LevelJump Closes Private Placement Raising Gross Proceeds of over $877,000

Staff July 4, 2022

Toronto, Ontario--(Newsfile Corp. - July 4, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...

wellteq Digital Health Inc. Announces Director Resignation

Staff July 4, 2022

Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - wellteq Digital Health Inc. (CSE: WTEQ) (OTCQB: WTEQF), (the "Company" or...

Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update

Staff July 4, 2022

Company also provides bi-weekly MCTO status updateVancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE:...

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Staff July 4, 2022

GENEVA, SWITZERLAND / ACCESSWIRE / July 4, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), announced...

Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk

Staff July 4, 2022

GENEVA, SWITZERLAND / ACCESSWIRE / July 4, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF, RLFTY) (" Relief "), a...

ALK spotlights the impact of respiratory allergies on children at EAACI Congress

Staff July 3, 2022

Four leading experts in respiratory allergy spotlight the impact of respiratory allergy in children, in an ALK-sponsored symposium at the...

VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

Staff July 2, 2022

Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a...

Innovation Vista Named Most Promising Digital Transformation Firm

Staff July 1, 2022

Los Angeles, California--(Newsfile Corp. - July 1, 2022) - CIO Review announces Innovation Vista as Most Promising Emerging Digital Transformation...

ClexBio Announces New Appointments to Board of Directors

Staff July 1, 2022

OSLO, Norway & BOSTON--(BUSINESS WIRE)--ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment...

ProAssurance Second Quarter 2022 Results Release and Teleconference

Staff July 1, 2022

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended June 30, 2022 after the close of normal...

Philips Signs Health Care Sector Pledge to Reduce Emissions as part of Department of Health and Human Services, White House Initiative

Staff July 1, 2022

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has joined...

Vaxart Provides an Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022 to Vote by July 5, 2022, at 11:59 p.m. ET

Staff July 1, 2022

Key Proposal #2 has received significant support, but additional votes are needed for approval Leading Independent Proxy Advisory Firms, ISS...

Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors

Staff July 1, 2022

BOSTON and LONDON, July 01, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company with a...

Biomea Fusion Selected for Two Oral Presentations at the European Association for the Study of Diabetes Annual Meeting Describing BMF-219’s Potential as a Novel, Oral, Long-Acting, Acute Treatment for Type 2 Diabetes

Staff July 1, 2022

Biomea to present two oral abstracts across multiple animal models highlighting the ability of BMF-219, a covalent menin inhibitor, to...

Month: July 2022

AlzeCure Gets Abstract on New Clinical Study Data with NeuroRestore Accepted at the Alzheimer’s Conference AAIC

Pharnext Appoints Antoine Gravelle as General Counsel

Evotec Completes Acquisition of Rigenerand

LevelJump Closes Private Placement Raising Gross Proceeds of over $877,000

wellteq Digital Health Inc. Announces Director Resignation

Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk

ALK spotlights the impact of respiratory allergies on children at EAACI Congress

VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

Innovation Vista Named Most Promising Digital Transformation Firm

ClexBio Announces New Appointments to Board of Directors

ProAssurance Second Quarter 2022 Results Release and Teleconference

Philips Signs Health Care Sector Pledge to Reduce Emissions as part of Department of Health and Human Services, White House Initiative

Vaxart Provides an Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022 to Vote by July 5, 2022, at 11:59 p.m. ET

Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors

Biomea Fusion Selected for Two Oral Presentations at the European Association for the Study of Diabetes Annual Meeting Describing BMF-219’s Potential as a Novel, Oral, Long-Acting, Acute Treatment for Type 2 Diabetes

GeneType Risk Assessment Test onboarding in 16 clinics

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Results of Annual General Meeting

Global Live Cell Imaging Market: Advances and Growth Prospects

Tareen Development Partners Acquires Town Centre Plaza in Eagan and Will Rebrand as Eagan Medical Center

SPOC Grid Inverter Technologies Appoints Energy Leader Clayton Gibbons to Advance Onsite Power Vertical

Greenway Health Enhances UDS Reporting with UDS+ Capability for FQHCs

West Monroe Acquires Inspired Health to Add Market Research and Insights Capabilities in Life Sciences Sector, Establishes New Boston Office

You may have missed